CIC bioGUNE, Bizkaia Technology Park, Derio, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (Ciberehd), Madrid, Spain.
J Extracell Vesicles. 2016 Feb 15;5:29497. doi: 10.3402/jev.v5.29497. eCollection 2016.
Urine sample analysis is irreplaceable as a non-invasive method for disease diagnosis and follow-up. However, in urine samples, non-degraded protein and RNA may be only found in urinary extracellular vesicles (uEVs). In recent years, various methods of uEV enrichment using low volumes of urine and unsophisticated equipment have been developed, with variable success. We compared the results of the differential ultracentrifugation procedure with 4 of these methods. The methods tested were a lectin-based purification, Exoquick (System Biosciences), Total Exosome Isolation from Invitrogen and an in-house modified procedure employing the Exosomal RNA Kit from Norgen Biotek Corp. The analysis of selected gene transcripts and protein markers of extracellular vesicles (EVs) revealed that each method isolates a different mixture of uEV protein markers. In our conditions, the extraction with Norgen's reagent achieved the best performance in terms of gene transcript and protein detection and reproducibility. By using this method, we were able to detect alterations of EVs protein markers in urine samples from prostate cancer adenoma patients. Taken together, our results show that the isolation of uEVs is feasible from small volumes of urine and avoiding ultracentrifugation, making easier the analysis in a clinical facility. However, caution should be taken in the selection of the enrichment method since they have a differential affinity for protein uEVs markers and by extension for different subpopulation of EVs.
尿液样本分析作为一种非侵入性的疾病诊断和随访方法是不可替代的。然而,在尿液样本中,只有未降解的蛋白质和 RNA 可能存在于尿细胞外小泡(uEVs)中。近年来,已经开发出了各种使用少量尿液和简单设备富集 uEV 的方法,成功率各不相同。我们比较了差速离心程序与其中 4 种方法的结果。测试的方法是基于凝集素的纯化、Exoquick(System Biosciences)、 Invitrogen 的总外泌体分离和采用 Norgen Biotek Corp 的外泌体 RNA 试剂盒的内部改良程序。对选定的基因转录物和细胞外囊泡(EVs)的蛋白标志物的分析表明,每种方法都分离出不同的 uEV 蛋白标志物混合物。在我们的条件下,Norgen 试剂的提取在基因转录物和蛋白检测及重现性方面表现最佳。通过使用这种方法,我们能够检测到前列腺癌腺瘤患者尿液样本中 EVs 蛋白标志物的改变。总之,我们的结果表明,从小体积的尿液中分离 uEVs 是可行的,并且可以避免超速离心,从而更容易在临床设施中进行分析。然而,在选择富集方法时应谨慎,因为它们对 uEVs 蛋白标志物的亲和力不同,因此对不同的 EVs 亚群的亲和力也不同。